Cargando…
Increased Expression of Histone Proteins during Estrogen-Mediated Cell Proliferation
BACKGROUND: There is concern about the potential risk posed by compounds with estrogen-like activity present in the environment. As previous studies have shown that combined exposure to such compounds results in dose additivity, it should be possible to assess estrogen exposure with suitable biomark...
Autores principales: | Zhu, Zheying, Edwards, Robert J., Boobis, Alan R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
National Institute of Environmental Health Sciences
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2702408/ https://www.ncbi.nlm.nih.gov/pubmed/19590685 http://dx.doi.org/10.1289/ehp.0800109 |
Ejemplares similares
-
Synergy between histone deacetylase inhibitors and DNA-damaging agents is mediated by histone deacetylase 2 in colorectal cancer
por: Alzoubi, Samer, et al.
Publicado: (2016) -
Increased ETV4 expression correlates with estrogen-enhanced proliferation and invasiveness of cholangiocarcinoma cells
por: Singsuksawat, Ekapot, et al.
Publicado: (2018) -
Testicular Dysgenesis Syndrome and the Estrogen Hypothesis: A Quantitative Meta-Analysis
por: Martin, Olwenn V., et al.
Publicado: (2008) -
Estrogen/estrogen receptor promotes the proliferation of endometrial carcinoma cells by enhancing hMOF expression
por: Qi, Yue, et al.
Publicado: (2020) -
Histone deacetylase inhibitors enhance estrogen receptor beta expression and augment agonist-mediated tumor suppression in glioblastoma
por: Pratap, Uday P, et al.
Publicado: (2021)